Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

BioCryst Pharmaceuticals Company Profile (NASDAQ:BCRX)

Consensus Ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) (?)
Ratings Breakdown: 3 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $16.90 (47.99% upside)

Current Analysts' Coverage Summary for BioCryst Pharmaceuticals (NASDAQ:BCRX)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2015ZacksDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015FBR & Co.Initiated CoverageOutperform$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Bank of AmericaUpgradeUnderperform -> Neutral$8.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Needham & Company LLCSet Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014MLV & Co.Set Price TargetBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014JPMorgan Chase & Co.Lower Price TargetOverweight$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014Wells Fargo & Co.UpgradeMarket Perform -> Outperform$19.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/30/2014HC WainrightBoost Price TargetBuy$21.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2014Roth CapitalBoost Price Target$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014Brinson PatrickInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Piper JaffrayInitiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014MizuhoInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2014JMP SecuritiesReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)